Neuropathy & HIV/AIDS: Research

See also: Neuropathy & HIV/AIDS

High Prevalence of Peripheral Neuropathy in Children Taking d4T in Rural South Africa (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Peripheral Neuropathy in South African Children Highlights Limited ARV Choices (July 23, 2012)
From aidsmap.com
Pfizer Halts Late-Stage Study Into New Lyrica Use (May 7, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Capsaicin Patch for Neuropathy Granted FDA Review (November 23, 2011)
In Positively Aware, from Test Positive Aware Network
Neurologic Complications of HIV Disease and Their Treatment (April-May 2009)
In Topics in HIV Medicine
Peripheral Neuropathy Still Common Among HIV-Infected Patients on HAART; Risk May Increase With Age (February 10, 2009)
A metastudy of ACTG trial participants finds peripheral neuropathy prevalence of greater than 20% among patients initiating HAART -- a proportion that increases as patients age, despite maintaining a CD4+ cell count above 350 and a viral load below 400, and despite declining use of didanosine and stavudine. Study presenter Scott Evans, Ph.D., also notes that neuropathy usually occurred without patients experiencing any pain whatsoever.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Pain Patch for Neuropathy Fails in Study (March 18, 2008)
From Project Inform
Neuropathic Pain: Redefinition and a Grading System for Clinical and Research Purposes (November 14, 2007)
In Neurology
Pattern of HIV-Related Central Nervous System Disorders Varies by Region, Evolving Alongside Access to Antiretroviral Therapy (April 27, 2007)
From aidsmap.com
HIV JournalView: An Alternative for Peripheral Neuropathy (August 2004)
Analysis of a study published in the journal AIDS on acetyl-l-carnitine.
From TheBodyPRO.com

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	CROI 2013: Women's Issues in HIV Research (Video)
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013
	HIV Opportunistic Infection Guidelines Updated

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.